Have a personal or library account? Click to login
Curcumin phytosomal softgel formulation: Development, optimization and physicochemical characterization Cover

Curcumin phytosomal softgel formulation: Development, optimization and physicochemical characterization

Open Access
|Sep 2015

References

  1. 1. R. K. Maheshwari, A. K. Singh, J. Gaddipati and R. C. Srimal, Multiple biological activities of curcumin: a short review, Life Sci.78 (2006) 2081–2087; DOI: 10.1016/j.lfs.2005.12.007.10.1016/j.lfs.2005.12.00716413584
  2. 2. R. Sharma, C. Ireson, R. Verschoyle, K. Hill, M. Williams, C. Leuratti, M. Manson, L. Marnett and W. Steward, Effects of dietary curcumin on glutathione-S-transferase and malondialdehyde-DNA adducts in rat liver and colon mucosa: relationship with drug levels, Clin. Cancer Res.7 (2001) 1452–1458.
  3. 3. R. A. Sharma, S. A. Euden, S. L. Platton, D. N. Cooke, A. Shafayat, H. R. Hewitt, T. H. Marczylo, B. Morgan and D. Hemingway, Phase I clinical trial of oral curcumin: Biomarkers of systemic activity and compliance, Clin. Cancer Res.10 (2004) 6847–6854.
  4. 4. A. Paradkar, A. A. Ambike, B. K. Jadhav and K. R. Mahadik, Characterization of curcumin-PVP solid dispersion obtained by spray drying, Int. J. Pharm.271 (2004) 281–286; DOI: 10.1016/j.ijpharm.2003.11.014.10.1016/j.ijpharm.2003.11.01415129995
  5. 5. M. H. Leung, H. Colangelo and T. W. Kee, Encapsulation of curcumin in cationic micelles suppresses alkaline hydrolysis, Langmuir.24 (2008) 5672–5675; DOI: 10.1021/la800780w.10.1021/la800780w18459746
  6. 6. T. H. Kim, H. H. Jiang, Y. S. Youn, C. W. Park, K. K. Tak, S. Lee, H. Kim and S. Y. Jon, Preparation and characterization of water-soluble albumin bound curcumin nanoparticles with improved antitumor activity, Int. J. Pharm.403 (2011) 285–591; DOI: 10.1016/j.ijpharm.2010.10.041.10.1016/j.ijpharm.2010.10.04121035530
  7. 7. Y. B. Pawar, H. Purohit, G. Valicherla, B. Munjal, S. V. Lale, S. Patel and A. K. Bansal, Novel lipid based oral formulation of curcumin: development and optimization by design of experiments approach, Int. J. Pharm.436 (2012) 617–623; DOI: 10.1016/j.ijpharm.2012.07.031.10.1016/j.ijpharm.2012.07.03122842624
  8. 8. J. Cui, B. Yu, Y. Zhao, W. Zhu, H. Li and H. Lou, Enhancement of oral absorption of curcumin by self-microemulsifying drug delivery systems, Int. J. Pharm.371 (2009) 148–155; DOI: 10.1016/j.ijpharm.2008.12.009.10.1016/j.ijpharm.2008.12.00919124065
  9. 9. C. G. Chen, T. D. Johnston, H. Jeon, R. Gedaly, P. P. McHugh, T. G. Burke and D. Ranjan, An in vitro study of liposomal curcumin: stability, toxicity and biological activity in human lymphocytes and Epstein-Barr virus-transformed human B cells, Int. J. Pharm.366 (2009) 133–139; DOI: 10.1016/j.ijpharm.2008.09.009.10.1016/j.ijpharm.2008.09.00918840516
  10. 10. K. Maiti, K. Mukherjee, A. Gantait, B. Saha and P. K. Mukherjee, Curcumin-phospholipid complex: Preparation, therapeutic evaluation and pharmacokinetic study in rats, Int. J. Pharm.330 (2007) 155–163; DOI: 10.1016/j.ijpharm.
  11. 11. N. K. Gupta and V. K. Dixit, Bioavailability enhancement of curcumin by complexation with phosphatidylcholine, J. Pharm. Sci.100 (2011) 1987–1995; DOI: 10.1002/jps.22393.10.1002/jps.2239321374628
  12. 12. J. Zhang, Q. Tang, X. Xu and N. Li, Development and evaluation of a novel phytosome-loaded chitosan microsphere system for curcumin delivery, Int. J. Pharm.448 (2013) 168–174; DOI: 10.1016/j.ijpharm.2013.03.021.10.1016/j.ijpharm.2013.03.02123524117
  13. 13. P. Shivanand and P. Kinjal, Phytosomes: Technical revolution in phytomedicine, Int. J. PharmaTechRes.2 (2010) 627–631.
  14. 14. J. Patel, R. Patel, K. Khambholja and N. Patel, An overview of phytosomes as an advanced herbal drug delivery system, Asian J. Pharm. Sci.4 (2009) 363–371.
  15. 15. A. Semalty, M. Semalty, B. S. Rawat, D. Singh and M. S. Rawat, Pharmacosomes: the lipid-based new drug delivery system, Expert Opin. Drug Deliv.6 (2009) 599–612; DOI: 10.1517/17425240902967607.10.1517/1742524090296760719519287
  16. 16. http://www.phytosomes.info/public/meriva.asp
  17. 17. H. I. Benza and W. L. Munyendo, A review of progress and challenges in soft gelatin capsules formulations for oral administration, Int. J. Pharm. Sci. Rev. Res.10 (2011) 20–24.
  18. 18. R. P. Gullapalli, Soft gelatin capsules (softgels), J. Pharm. Sci.99 (2010) 4109–4121; DOI: 10.1002/jps.22151.10.1002/jps.2215120737624
  19. 19. W. J. Jones, Softgels: consumer perceptions and market impact relative to other oral dosage forms, Adv. Ther.17 (2000) 213–221.
  20. 20. L. L. Schramm, Emulsions, Foams, and Suspensions: Fundamentals and Applications, Wiley, Weinheim 2005.10.1002/3527606750
  21. 21. M. Brewster, R. Vandecruys, J. Peeters, P. Neeskens and G. Verreck, Comparative interaction of 2-hydroxypropyl cyclodextrin and sulfobutylether-cyclodextrin with itraconazole: phase-solubility behavior and stabilization of supersaturated drug solutions, Eur. J. Pharm. Sci.34 (2008) 94–103; DOI: 10.1016/j.ejps.2008.02.007.10.1016/j.ejps.2008.02.00718420390
  22. 22. M. S. Freag, Y. S. Elnaggar and O. Y. Abdallah, Lyophilized phytosomal nanocarriers as platforms for enhanced diosmin delivery: optimization and ex vivo permeation, Int. J. Nanomed.8 (2013) 2385–2397; DOI: 10.2147/IJN.S45231.10.2147/IJN.S45231370443823861584
  23. 23. F. Zhang, G. Y. Koh, D. P. Jeansonne, J. Hollingsworth, P. S. Russo, G. Vicente, R. W. Stout and Z. Liu, A novel solubility-enhanced curcumin formulation showing stability and maintenance of anticancer activity, J. Pharm. Sci.100 (2011) 2778–89; DOI: 10.1002/jps.22512.10.1002/jps.2251221312196
  24. 24. Soybean Phospholipids, in Recent Trends for Enhancing the Diversity and Quality of Soybean (Ed. D. Krezhova), InTech 2011, pp. 483–450.
  25. 25. Z. Hou, Y. Li, Y. Huang, C. Zhou, J. Lin, Y. Wang, F. Cui, S. Zhou, M. Jia, S. Ye and Q. Zhang, Phytosomes loaded with mitomycin C-soybean phosphatidylcholine complex developed for drug delivery, Mol. Pharm.10 (2013) 90–101; DOI: 10.1021/mp300489p.10.1021/mp300489p23194396
  26. 26. M. A. Elsheikh, Y. S. Elnaggar, E. Y. Gohar and O. Y. Abdallah, Nanoemulsion liquid preconcentrates for raloxifene hydrochloride: optimization and in vivo appraisal, Int. J. Nanomed.7 (2012) 3787–3802; DOI: 10.2147/IJN.S33186.10.2147/IJN.S33186341422422888234
  27. 27. X. Ren, X. Mao, L. Si, L. Cao and H. Xiong, Pharmaceutical excipients inhibit cytochrome P450 activity in cell free systems and after systemic administration, Eur. J. Pharm. Biopharm.70 (2008) 279–288; DOI: 10.1016/j.ejpb.2008.03.019.10.1016/j.ejpb.2008.03.01918499414
  28. 28. X. Ren, X. Mao, L. Si, L. Cao and J. Qiu, Nonionic surfactants are strong inhibitors of cytochrome P450 3A biotransformation activity in vitro and in vivo, Eur. J. Pharm. Biopharm.36 (2009) 401–411; DOI: 10.1016/j.ejps.2008.11.002.10.1016/j.ejps.2008.11.00219041719
  29. 29. B. Wahlang, Y. B. Pawar and A. K. Bansal, Identification of permeability-related hurdles in oral delivery of curcumin using the Caco-2 cell model, Eur. J. Pharm. Biopharm.77 (2011) 275–282; DOI: 10.1016/j.ejpb.2010.12.006.10.1016/j.ejpb.2010.12.00621147222
  30. 30. S. A. Saraf, Applications of novel drug delivery system for herbal formulations, Fitoterapia81 (2010) 680–689; DOI: 10.1016/j.fitote.2010.05.001.10.1016/j.fitote.2010.05.00120471457
DOI: https://doi.org/10.1515/acph-2015-0029 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Language: English
Page range: 285 - 297
Accepted on: Jun 25, 2015
Published on: Sep 30, 2015
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:

© 2015 Ahmed N. Allam, Ibrahim A. Komeil, Ossama Y. Abdallah, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.